|
 
 |
| EDITOR'S PAGE |
|
| Year : 2022 | Volume
: 11
| Issue : 3 | Page : 63 |
|
Editor's Page July 2022
Ravi R Kasliwal
Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurugram, Haryana, India
| Date of Web Publication | 21-Nov-2022 |
Correspondence Address:
MD, DM, FIMSA, MNAMS, FASE Ravi R Kasliwal
Chairman, Clinical and Preventive Cardiology, Medanta - The Medicity, Sector 38, Gurugram - 122 001, Haryana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2250-3528.361696
How to cite this article:
Kasliwal RR. Editor's Page July 2022. J Clin Prev Cardiol 2022;11:63 |
Dear Readers,
This issue comes to you in the thick of summer for a great part of India, with rains already having made their presence in other parts. The same dichotomy is observed in the articles that I present to you in the July issue.
The first article, an original contribution titled “Relationship between blood pressure Variables (Systolic Blood Pressure, Diastolic Blood Pressure, Pulse Pressure and Mean Arterial Pressure) and Left Atrial Measurements among Hypertensive Subjects in a Tertiary Hospital in South-South Nigeria” by Dr. Aiwuyo Osarume Henry and colleagues from Nigeria in 200 hypertensive patients and 100 controls with normal BP, shows increased left atrial volume in the former group. The authors conclude that “The size of the left atrium relates positively with blood pressure variables.” The study has implications for the occurrence of atrial fibrillation to congestive heart failure in hypertensive patients.
The second original article from Hyderabad, India, “Prognostic Significance of Serum Cholinesterase in Acute Myocardial Infarction” authored by Dr. Parvathareddy and colleagues is a thought-provoking scientific contribution on the value of estimation of serum cholinesterase in acute myocardial infarction. The authors believe that persistently low figures of cholinesterase levels at admission may shed light on the occurrence of major adverse cardiovascular events in ST-segment elevation myocardial infarction patients.
The third article from Cyprus is extremely timely and titled “Cardiac Surgery-Associated Acute Kidney Injury: The Core of Etiology, Treatment and Prognosis.” It is authored by Dr. DC Karathanasis and colleagues and clearly demonstrates the value of early recognition of factors that may predispose our patients to acute kidney injury, which increases morbidity and mortality in these patients already at high risk. A good review of the state-of-the-art.
The fourth article is from the Medanta group Dr. Narendra Singh Choudhary and colleagues and is titled “Drug-Induced Liver Injury: A Primer for Cardiologists.” So, from renal injury to liver injury! Again a timely reminder of what can be prevented. Although rare, lethal. The bottom line is that given the list of commonly used cardiac medications, liver function test assessment at appropriate time points is necessary, and any aberration in the liver enzyme levels should be diligently addressed.
These two reviews clearly demonstrate the value of relevant clinical knowledge and the power of early recognition and thus prevention.
The letter to editor is an interesting read on the saga of monkeypox. In some cases, the presentation of monkeypox can even be chest pain.
The current edition of the Journal of Clinical and Preventive Cardiology is a mix of articles from three countries. Each is thought provoking and clinically relevant.
Happy reading!
|
Search Pubmed for